The objectives of this study were to determine the effects of oral Gln supplementation on growth performance, intestinal morphology, and expression of heat shock protein (Hsp) 70 in weaning piglets. A total of 65 piglets after weaning at 21 d of age (d 0) were used in this experiment. Five piglets were randomly selected and euthanized initially at d 0 to determine baseline values for the expression of Hsp70 in the small intestine. The remaining piglets were randomly assigned to 1 of 2 treatments and received 0 or 1 g of oral Gln/kg of BW every 12 h. After piglets were humanely killed at d 3, 7, and 14 postweaning, the duodenum, jejunum, and ileum of piglets were sampled to evaluate intestinal morphology and the expression and localization of Hsp70. The results indicated that oral Gln supplementation increased plasma concentrations of Gln compared with those in control piglets (P < 0.05). Average daily gain and ADFI were greater in piglets orally supplemented with Gln than in control piglets during the whole period (P < 0.05). The incidence of diarrhea in piglets orally supplemented with Gln was 24% less than (P = 0.064) that in control piglets at 8 to 14 d after weaning. The weights of the jejunum and ileum were greater in piglets orally supplemented with Gln compared with those of control piglets relative to BW on d 14 postweaning (P < 0.05). The villus height and the villus height:crypt depth ratio in the jejunum and the ileum were greater in piglets receiving oral Gln on d 14 postweaning (P < 0.05) than in control piglets. These results indicate that Gln supplementation can influence the intestinal morphology of weaned piglets. The expression of hsp70 mRNA and Hsp70 proteins in the duodenum and jejunum was greater in piglets supplemented with Gln than in control piglets (P < 0.05). However, Gln supplementation had no effect on the expression of hsp70 mRNA and Hsp70 proteins in the ileum. Moreover, the localization of Hsp70 in the cytoplasm indicated that Hsp70 has a cytoprotective role in epithelial cell function and structure. These results indicate that Gln supplementation may be beneficial for intestinal health and development and may thus mitigate diarrhea and improve growth performance. The protective mechanisms of Gln in the intestine may be associated with the increase in Hsp70 expression.
INTRODUCTION
After weaning, neonates often experience depressed feed intake and growth, reduced villus height, and increased crypt depth. Sakiyama et al. (2009) showed that Gln can prevent these gut problems. However, the underlying mechanisms were not completely elucidated.
Glutamine is the most abundant free AA in blood, tissue fluids, and the milk of mammals (Wu et al., 1995) . When the body suffers injury from various stresses, the demand for Gln is increased and the endogenous supply of Gln is insufficient (Wu, 1998) . Studies have shown that Gln promotes cell proliferation and exerts cytoprotective effects in response to nutrient deprivation, oxidative injury, and immunological challenge (Haynes et al., 2009 ). It has also been reported that Gln supplementation increases intestinal villus height, prevents bacterial infections, and maintains gut integrity (Wu et al., 1996 (Wu et al., , 2007 . Furthermore, Gln plays a role in acti-vating intracellular signaling pathways and regulating the expression of genes (Wu 2009; Brasse-Lagnel et al., 2010) . However, little is known about the effect of Gln on the expression of heat shock protein (Hsp) in the intestines of weaning piglets.
Heat shock protein 70 is a molecular chaperone involved in the folding of nascent and misfolded protein under normal conditions. Overexpression of Hsp70 has been shown to protect intestinal epithelial cells from toxic agents and ulcerogenic conditions in gastrointestinal mucosa (Oyake et al., 2006) and can accelerate ulcer healing by promoting cell proliferation, inhibiting cell apoptosis, and accelerating protein synthesis (Pierzchalski et al., 2006) . The objectives of this study were to investigate the effects of Gln supplementation on growth performance, intestinal morphology, and expression of Hsp70 in weaning piglets.
MATERIALS AND METHODS
The experimental protocol was in accordance with the Guide for the Care and Use of Laboratory Animals prepared by the Institutional Animal Care and Use Committee, Nanjing Agricultural University, Nanjing, China.
Animals and Experimental Design
All piglets used in this study were offspring of Large White × Landrace sows (Jiangsu Kangle Agricultural and Pastoral Co. Ltd., Changzhou, Jiangsu, China). The piglets were weaned at 21 d of age. Creep feed was not provided before weaning. A total of 65 piglets from 13 litters (weaning BW, 6.5 ± 0.5 kg) were used in this experiment. Five piglets were randomly selected and euthanized initially at 21 d of age (d 0) to determine baseline values for the expression of Hsp70 in the small intestine. The remaining piglets were randomly assigned to 1 of 2 treatments (control or oral Gln supplementation), with 5 pens per treatment and 6 piglets per pen. Piglets were housed in pens with slatted steel floors in an environmentally controlled room (27.0 ± 0.5°C). Piglets were allowed to consume feed and water ad libitum. The diet (Table 1 ) met the NRC (1998) requirements for nutrients. Piglets received 0 g (control) or 1 g of Gln/kg of BW every 12 h, which is thought to be the appropriate amount to protect intestinal mucosal cells (Burrin et al., 1991) . The Gln was mixed with distilled water at room temperature and slowly administered with a 10-mL syringe into the mouths of the piglets. Alanine was used to make the dose isonitrogenous in control piglets, as described by Kim and Wu (2004) . Body weights of piglets and ADFI were recorded on d 3, 7, and 14 postweaning. At each time point, fecal scores (1 = normal, solid feces; 2 = soft, looser than normal feces, slight diarrhea; 3 = moderate diarrheic feces; and 4 = liquid, severe diarrheic feces) were recorded for all piglets. The incidence of diarrhea in the piglets was calculated as [(number of piglets with diarrhea × number of days of diarrhea)/ (number of piglets × number of days of experiment)] × 100 (Zhan et al., 2008) .
Sample Collection
One hour after feeding on d 3, 7 and 14 postweaning, 1 piglet per pen (n = 5) was euthanized using an injection of sodium pentobarbital (50 mg/kg of BW), and blood samples (approximately 5 mL) were obtained from a jugular vein using a 10-mL tube with sodium heparin (17 IU/mL). Plasma was obtained after centrifugation at 3,000 × g for 15 min at 4°C and stored at −80°C. The duodenum, jejunum, and ileum were weighed and their lengths were measured after careful removal of luminal contents and rinses with saline. One sample of approximately 1 cm in length from each intestinal segment was stored for histological and immunohistochemical analyses. The sample was fixed in 4% paraformaldehyde in 100 mmol/L of phosphate buffer (pH 7.4) for 24 h. The mucosa of the rest of the intestine was scraped off with a glass slide and immediately placed in liquid nitrogen for the analysis of protein and mRNA.
Plasma Gln Analysis
Concentrations of Gln in plasma were analyzed using the HPLC method involving precolumn derivatiza- tion with o-phthaldialdehyde. All chromatographic procedures were performed at room temperature, and the samples and standards were analyzed in duplicate. The mean recovery and interassay CV were 102.5 and 2.51%, respectively, for determination of Gln.
Morphological Analyses
Paraformaldehyde-fixed and paraffin-embedded tissue sections (6 µm thick) were stained with hematoxylin and eosin. Villus height (from the tip of the villus to the villus-crypt junction) and crypt depth (from the villus-crypt junction to the lower limit of the crypt) were analyzed under a light microscope (Olympus, Tokyo, Japan), as described previously (Zhong et al., 2010) .
Semiquantitative Detection of Hsp70 by ELISA
After complete washing in ice-cold physiological saline, the intestinal mucosa samples were homogenized in cold solution (200 mg of tissues/mL) containing 0.15 M NaCl, 20 mM Tris-HCl (pH 8.0), 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 0.1 µM E-46 (Sigma, St. Louis, MO), 0.08 µM aprotinin, 0.1 µM leupetin, and 0.1% NP-40 (Sigma) with a homogenizer (UltraTurrax, IKA, Nanjing, China) on ice, and the homogenates were then centrifuged at 12,000 × g for 20 min at 4°C. The supernatant fluid was collected and stored at −20°C for protein quantification.
The concentrations of Hsp70 in the intestines of piglets were determined using commercially available ELISA kits (goat anti-porcine Hsp70, Adlitteram Diagnostic Laboratories, San Diego, CA). Quantification of samples was performed using a standard curve. The β-actin (goat anti-porcine β-actin, Adlitteram Diagnostic Laboratories) was used to normalize the results. Immunological detection of the proteins was performed according to the manual. The mean recovery in this trial was 96.3% (CV = 5.21%).
Quantitative Detection of hsp70 mRNA by Real-Time PCR
Total RNA was isolated from the sample of intestine mucosa using Trizol reagent (Invitrogen, Carlsbad, CA) and then treated by deoxyribonuclease I to remove the contaminant DNA. From each sample, 2 µg of RNA was used to synthesize cDNA in a 25-µL reaction mixture at 42°C for 60 min with a reverse transcriptase (M-MLV, Promega, San Luis Obispo, CA) using oligo dT18 (Takara, Dalian, China). The resultant cDNA was then diluted in ribonuclease-free water and kept at −20°C for real-time PCR.
Sequences of the hsp70 mRNA and GAPDH (glyceraldehyde 3-phosphate dehydrogenase) mRNA were obtained from GenBank (accession numbers X68213 and CV874334, respectively; National Center for Biotechnology Information, Bethesda MD). The primer sequences were as follows: hsp70 sense primer 5′-GCCCTGAATCCGCAGAATA-3′, antisense primer 5′-TCCCCACGGTAGGAAACG-3′; GAPDH sense primer 5′-GAAGGTCGGAGTGAACGGAT-3′, and antisense primer 5′-CATGGGTAGAATCATACTG-GAACA-3′. The real-time PCR was performed (in an ABI 7300 reverse-transcription PCR system, Applied Biosystems, Carlsbad, CA) using a kit (SYBR Premix ExTaq, Takara, Dalian, China). Amplifications were carried out at a final volume of 20 µL of reaction mixture [10 µL of SYBR Premix ExTaq buffer (which included Takara ExTaq HS, a deoxynucleotide 5′-triphosphate mixture, Mg
2+
, and SYBR Green I), Takara], 0.4 µL of forward primer (0.2 µmol/L), 0.4 µL of reverse primer (0.2 µmol/L), 0.4 µL of dye (ROX Reference Dye, Takara), 2 µL of cDNA template, and 6.8 µL of distilled H 2 O. The thermal profile for real-time PCR was 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The fluorescence output of each cycle was measured after the completion of the entire run. Cycle threshold values were calculated by software (SDS software algorithms, Applied Biosystems) and converted into an equivalent target amount using the standard curve established by the calibrator. For a standard curve, 10-fold dilutions of recombinant pGEM-T (Promega, Madison, WI) plasmids were made to give 10 6 to 10 1 copies/mL.
Localization of Hsp70 by Immunohistochemistry
The sections of the intestine were examined immunohistochemically using the streptavidin-biotin-peroxidase complex procedure (Zymed Laboratories Inc., South San Francisco, CA). The slices were dewaxed through 2 steps of xylene washings. After being dewaxed and rehydrated, the sections were microwave-heated for 10 min in 0.01 M sodium citrate buffer (pH 6.0). Endogenous peroxidase activity was quenched with 3% H 2 O 2 for 10 min at room temperature. Nonspecific binding of the antiserum was blocked by incubating the sections for 20 min at room temperature in a blocking solution containing 10% normal goat serum. Sections were then overlaid at 4°C overnight with 1:100 diluted mouse anti-Hsp70 monoclonal antibody (SPA-810, Stressgen, Victoria, British Columbia, Canada). After washing in PBS, the slides were incubated for 60 min at room temperature with the corresponding secondary biotinylated mouse antibody (Zymed Laboratories Inc.) at a 1:300 dilution in 1% BSA-PBS (pH 7.4). Subsequently, the sections were subjected to 3 washes of PBS and incubated for 60 min in a horseradish peroxidase-streptavidin solution (Zymed Laboratories Inc.) and washed in PBS again. Positive cells were stained a brown color using 3,3′-diaminobenzidine tetrachloride as the enzyme substrate. After rinsing in distilled water, the slides were counterstained with Mayer's hematoxylin for 3 s and then mounted. The corresponding negative control sections were prepared by omitting the primary antibody (Zhong et al., 2010) .
Statistical Analysis
Growth performance and microscopic measurements data were analyzed by t-test (SPSS Inc., Chicago, IL). The difference in incidence of diarrhea between the control group and the Gln group was determined by a χ 2 test. The expression of Hsp70 protein and hsp70 mRNA was analyzed as a mixed model with treatment, age, BW, and treatment × age as fixed effects and piglet as a random effect using the MIXED procedure of SPSS. The measurements obtained at different ages (d 3, 7, and 14 postweaning) were treated as repeated measures, with piglet as the subject. Body weight was used as a covariate. Statistical significance was determined at P < 0.05. Table 2 summarizes the effect of oral Gln supplementation on growth performance and the incidence of diarrhea in weaned piglets. Oral Gln supplementation had no effect on ADFI, ADG, or G:F during the first week postweaning. During the second week postweaning, ADG and ADFI were greater in piglets orally supplemented with Gln than in control piglets (P < 0.05). Compared with the ADG and ADFI in control piglets, ADG and ADFI increased in piglets orally supplemented with Gln during the whole period (P < 0.05). Although no differences were observed in the incidence of diarrhea between the control group and the Gln group throughout the study, the occurrence of diarrhea was 24% less in piglets orally supplemented with Gln than that in control piglets on d 8 to 14 after weaning.
RESULTS

Growth Performance and Diarrhea
Plasma Concentrations of Gln
The plasma concentrations of Gln were determined on d 3, 7, and 14 after weaning (Table 3) . Oral Gln supplementation increased plasma concentrations of Gln compared with concentrations in control piglets (P < 0.05). Age affected plasma concentrations of Gln (P < 0.05). No treatment × age interactions were observed in plasma concentrations of Gln.
Intestinal Morphology
The results of the morphometric measurements are presented in Table 4 . The jejunal and ileal weights were greater in piglets orally supplemented with Gln than in control piglets relative to BW on d 14 postweaning (P < 0.05). No differences in length of the 3 intestinal segments between the control group and the Gln group were observed on d 3, 7, and 14 postweaning. No effect was observed on villus height, crypt depth, and the villus height:crypt depth ratio in the duodenum of weaned piglets supplemented with Gln on d 3 and 14 postweaning, respectively. However, villus height (P < 0.05) and villus height:crypt depth ratio (P = 0.061) were greater in the duodenum of piglets orally administered Gln compared with control piglets on d 7 after weaning. On d 7 and 14 postweaning, villus height and villus height:crypt depth ratio in the jejunum were greater in piglets supplemented with Gln than in control piglets.
In the ileum, the crypt depth and villus height were greater in piglets orally administered Gln than in those of control piglets on d 3 and 14 postweaning (P < 0.05). Tables 5 and 6 show the effect of oral Gln supplementation on the concentrations of hsp70 mRNA and proteins in the intestine of piglets, respectively. Because weaning caused spatial-temporal patterns of Hsp70 expression in the intestine of piglets, we tested the expression of Hsp70 proteins and hsp70 mRNA in the intestines on d 0, 3, 7, and 14 postweaning. Results indicated that the expression of hsp70 mRNA in the duodenum was greater (P < 0.05) in piglets orally supplemented with Gln than in control piglets. Although treatment × age interactions were observed in the jejunum and ileum (P < 0.05), the expression of hsp70 mRNA in the jejunum was greater in piglets orally supplemented with Gln than in control piglets. In contrast, oral Gln supplementation had no effect on the expression of hsp70 mRNA in the ileum. Age affected the expression of hsp70 mRNA in the jejunum and ileum.
Expression of Hsp70 Proteins and hsp70 mRNA in the Intestine
A treatment × age interaction was observed in the ileum, but this was only a trend. Similar to the expression of hsp70 mRNA, the concentrations of Hsp70 proteins in the duodenum and jejunum increased (P < 0.05); however, the concentrations of Hsp70 proteins were smaller in the ileum of piglets orally supplemented with Gln than in control piglets. Moreover, age affected the quantity of Hsp70 proteins in the duodenum and jejunum (P < 0.05) and also in the ileum.
Immunohistochemical Observation
Immunolabeling showed that the Hsp70 protein was mainly localized in the cytoplasm of epithelial cells (Figure 1 ). The signals of Hsp70 were detected pre- dominantly in the epithelial cells of the whole villi and intestinal gland rather than in the lamina propria and myenteron.
DISCUSSION
Glutamine, as a major energy substrate for rapidly dividing cells, has been used in animal studies and in clinical practice for providing a therapeutic strategy against postweaning syndrome (Wu et al., 1996; Rogero et al., 2008; Sakiyama et al., 2009) , which can be manifested as anorexia, intestinal atrophy, diarrhea, and growth retardation in mammalian neonates (Smith et al., 2010) . However, the underlying mechanisms are still not fully elucidated. The present data clearly demonstrated that oral Gln supplementation prevented intestinal atrophy, mitigated diarrhea, improved growth performance, and influenced the expression of hsp70 mRNA and proteins in the intestine of weaned piglets.
In our study, Gln supplementation had no effect on piglet performance during the first week of the experiment, perhaps because ADFI was decreased at the first week postweaning as a result of weaning stresses. During the second week and throughout the whole period, ADG and ADFI were improved by Gln supplementation, which is consistent with a previous report in piglets (Jiang et al., 2009 ). Furthermore, we showed that piglets orally supplemented with Gln had a decreased incidence of diarrhea, as indicated by the fecal scores on d 8 to 14 after weaning. Yi et al. (2005) also reported that 2% Gln supplementation could mitigate diarrhea in weaned pigs challenged with Escherichia coli K88 + . Oral Gln supplementation increased the concentrations of Gln in plasma. The greater Gln content may contribute to the maintenance of mucosal structure, especially the maintenance of tight junctions and permeability of intestinal mucosa (Panigrahi et al., 1997) , and thus the mitigation of diarrhea.
The morphology and functions of the gastrointestinal tract are remarkably impaired in weaned piglets (Moeser et al., 2007) . It has been reported that Gln supplementation stimulates the proliferation of intestinal enterocytes, increases intestinal villus height, prevents bacterial infections, and maintains gut integrity (Wu et al., 1996 (Wu et al., , 2007 Basivireddy et al., 2004) . Consistent with previous results, the present study showed that villus height and the villus height:crypt depth ratio in the jejunum were greater in piglets orally administered Gln on d 7 and 14 postweaning, respectively. In addition, the villus height in the ileum was substantially greater in piglets orally administered Gln than in control piglets on d 3 and 14 postweaning. The greater villus height and villus height:crypt ratio may improve nutrient absorption and thus growth performance (Bartell and Batal, 2007) . This was confirmed by our experimental data showing that ADG and ADFI were greater in piglets orally supplemented with Gln than in control piglets during the whole period. These results indicated that Gln supplementation could enhance the morphology and functions of the gastrointestinal tract in weaned piglets.
The Hsp are a family of stress-responsive proteins present in every organism, from bacteria to humans. According to molecular size, Hsp are classified into 4 major families, namely, small Hsp, Hsp60, Hsp70, and Hsp90 (Watanabe et al., 2004) . In the Hsp family, Hsp70 is one of the most abundant and best characterized proteins and is a molecular chaperone involved in the folding of nascent and misfolded proteins under normal conditions. Many studies have shown that Hsp70 protects the cells from various stresses (Oyake et al., 2006; Zhong et al., 2010) . Because Hsp70 is a universal cytoprotective protein, it may enhance the tolerance to environmental changes or pathogenic conditions, in- crease the survival rate of stressed cells, and also play a critical role in preventing the activation of inflammatory cells (Tang et al., 2007) . The Hsp70 has been shown to protect intestinal epithelial cells from toxic agents and ulcerogenic conditions in gastrointestinal mucosa, where it is an important location for digestion and the absorption and metabolism of nutrients, and it easily suffers injury from various stresses (Watanabe et al., 2004; Oyake et al., 2006; Zhong et al., 2010) . Overexpression of Hsp70 can accelerate ulcer healing by promoting cell proliferation, inhibiting cell apoptosis, and accelerating protein synthesis (Pierzchalski et al., 2006) . Therefore, it is important to understand the expression of Hsp70 in the intestines of weaning piglets, especially the regulation of Hsp70 by nutritional factors.
In addition to its role as an important energy substrate for epithelial cells of the small intestine, Gln plays critical roles in regulating protein turnover, regulating gene expression, and activating intracellular signaling pathways (Rogero et al., 2008; Brasse-Lagnel et al., 2010) . Recent studies have shown that exogenous Gln induce the expression of Hsp70 protein and hsp70 mRNA in normal conditions or under stressful situations (Hamiel et al., 2009; Zhang et al., 2009 ). Earlier, Nissim et al. (1993) reported that Gln without preincubation at 37°C remarkably increased the steady-state level of hsp70 mRNA, as well as the production of 72-and 73-kDa stress proteins in a dose-dependent manner. Ehrenfried et al. (1995) demonstrated that glutamine augments hsp70 mRNA and Hsp70 protein expression in gut-derived intestinal epithelial cells (IEC-6) cells after injury. In the present study, results indicated that the expression of hsp70 mRNA and Hsp70 proteins in the duodenum and the jejunum were greater in piglets orally supplemented with Gln than in control piglets. However, we found that oral Gln supplementation had no effect on the expression of hsp70 mRNA and Hsp70 proteins in the ileum. The different expression of Hsp70 among intestinal segments may be associated with Gln flux in the small intestine. In the gastrointestinal tract, more than 80% of all glutaminase activity (Gln metabolism assessed by the relative activities of glutaminase and Gln synthetase) is in the small intestine, and most of this is in the proximal small intestine (James et al., 1998) . In contrast, the activity of Gln synthetase is extremely low in the distal small intestine (James et al., 1998) . Therefore, it is likely that the Gln is taken up mainly by the proximal part of the small intestine.
The mechanism by which Gln enhances Hsp70 expression remains unclear. However, it seems to be independent of Gln metabolism (Sanders and Kon, 1992; Nissim et al., 1993) . Recently, Hamiel et al. (2009) reported that the induction of Hsp70 by Gln may be mediated by the hexosamine biosynthetic pathway. In addition, Singleton and Wischmeyer (2008) found that Gln induces hsp70 expression via O-glycosylation and phosphorylation of heat shock factor 1 and specificity protein 1 (Sp1). Glutamine is a rate-limiting substrate in the activity of the O-linked glycosylation pathway. The Sp1, a key promoter required for an optimal Hsp response after stress, is modified by the O-linked glycosylation pathway (Kudlow, 2006) . Glutamine activated the O-linked glycosylation pathway, subsequent O-glycosylation, and phosphorylation of Sp1 and heat shock factor protein 1 required for Hsp70 induction (Singleton and Wischmeyer, 2008) .
The localization of Hsp70 may be related to the protection function of molecular chaperones. In the present study, immunolabeling showed that the Hsp70 protein was mainly localized in the cytoplasm of epithelial cells. Goloubinoff and De Los Rios (2007) and Daugaard et al. (2007) also indicated that Hsp70 was primarily localized in the endoplasmic reticulum and the mitochondria. The localization of Hsp70 in the cytoplasm may play an important role in protecting the mitochondria. The mitochondria generate the greatest amount of ATP. However, under harmful stress conditions, mitochondrial ATP production would be impaired in cells (Selak et al., 2003; Simmons et al., 2005) . It has been confirmed that ATP depletion has detrimental effects on cell homeostasis, including protein aggregation, collapse of the cytoskeleton, and loss of ionic balance. In addition, the expression of Hsp70 was markedly induced by ATP depletion (Arispe et al., 2002; Martin et al., 2008) . Therefore, Hsp70 plays an important role in maintaining mitochondrial integrity, function, and capacity for ATP generation, which is very important for determining the survival of cells undergoing harmful stress injury. Furthermore, immunohistochemical results showed that the signals of Hsp70 were detected predominantly in the epithelial cells of the whole villi and intestinal gland rather than in the lamina propria and myenteron, consistent with our previous report (Zhong et al., 2010) . Those results indicated that Hsp70 had a cytoprotective role in epithelial cell function and structure.
In conclusion, oral Gln supplementation can maintain the morphology and functions of the intestines and improve growth performance in weanling piglets. The protective mechanisms of Gln in the intestines may be associated with an increase in Hsp70 expression in weaning piglets. 
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